IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
This study is currently recruiting participants.
Verified March 2017 by M. Van Ameringen, McMaster University
Sponsor:
Hamilton Health Sciences Corporation
Collaborator:
Pfizer
Information provided by (Responsible Party):
M. Van Ameringen, McMaster University
ClinicalTrials.gov Identifier:
NCT00994786
First received: October 5, 2009
Last updated: March 21, 2017
Last verified: March 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2019 |
| Estimated Primary Completion Date: | January 2019 (Final data collection date for primary outcome measure) |